US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201
THE WOODLANDS, Texas, July 20 /PRNewswire/ -- US Oncology, Inc . today announced that US Oncology Research will participate in the BiPar Sciences' Phase III, Multi-center, Open-Label, Randomized Trial of Gemcitabine/Carboplatin (G/C), with or without BSI-201, in p...
Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm
Local Vascular Surgeon Named National Principal Investigator
PHOENIX, June 19 /PRNewswire/ -- Surgeons from Arizona Heart Institute performed the first procedure in the U.S. Anaconda Phase II Study using the Vascutek Anaconda Stent Graft System , an investigational, minimally invasive trea...
Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
Antibody Targets Endosialin, a Protein Widely Expressed on Tumors and Tumor Blood Vessel Cells
EXTON, Pa., June 9 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced that the U.S. Food and Drug Administration (FDA) cleared its investigational
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride
NEW ORLEANS, June 8 /PRNewswire-FirstCall/ -- Novo Nordisk (NVO) data presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sugar and...
Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
ABBOTT PARK, Ill. and LONDON, June 4 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT ) and AstraZeneca announced today that the companies have submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for an investigational
compound for the treatment of mixed dyslipidemia...
XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
MENLO PARK, Calif., June 4 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced that the Company received conditional approval from the United States Food and Drug Administration (FDA) for an Investigational
Device Exemption (IDE) authorizing it to begin its pivotal clinical pro...
Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
RED-CABG Trial Initiates Patient Recruitment for Potentially Life-Saving Agent
KENILWORTH, N.J., May 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced the start of patient enrollment in RED-CABG, the Phase 3 Trial for acadesine, an investigational, potent...
Ethicon Endo-Surgery Novel Investigational Notes and SSL Devices Featured in 15 Presentations at Sages
CincinNAti, April 22 /PRNewswire/ -- Ethicon Endo-Surgery today announced the company's novel, investigational* devices, including its NOTES Toolbox(TM), are featured in 15 studies being presented at the 2009 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting. ...
Curemark Receives Investigational New Drug Clearance for CM-AT for Autism
Phase III Trial to Begin
RYE, N.Y., March 25 /PRNewswire/ -- Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational
New Drug (IND) appl...
Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
PRINCETON, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) today announced that it will receive a milestone payment of $1 million from its partner, MedImmune, LLC for the allowance of an Investigational
New Drug (IND) application for MEDI-546, a fully human antibody that tar...
Investigational in Medical Technology
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
CAMBRIDGE, Mass., Aug. 5 /PRNewswire/ -- Radius Health ("Radius") today announced topline Phase 2 data demonstrating that in women with osteoporosis, BA058 -- the company's novel PTHrP (parathyroid hormone-related protein) analog -- significantly increased bone mineral density (BM...
Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
COLLEGEVILLE, Pa., July 27 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced the publication in Fertility and Sterility of data from a Phase 3 clinical study that showed that the investigational
compound bazedoxifene/conjugated estrogens...
Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
DEERFIELD, Ill., July 22, and OSAKA, Japan, July 23 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification from the U.S. Food and Drug ...
UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201
US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational
Cancer Drug BSI-201
Phase II of the trial was presented in 2009 ASCO Plenary Session
US Oncology, Inc . today announced that US Oncology Research will participate...
First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
CINCINNATI, July 9 /PRNewswire/ -- Ethicon Endo-Surgery, Inc. today announced the successful treatment of the first patient of its IDE feasibility trial. The case, which was performed at The Ohio State University Center for Minimally Invasive Surgery, marks the first natural orifice translumen...
Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes
DEERFIELD, Ill., June 26, and OSAKA, Japan, June 27, 2009 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary received on June 26 (U.S. time) a complete response ...
Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162
NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Novo Nordisk (NVO) data presented today at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sug...
Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced today new, positive Phase II study results of LY2189265, its investigational
glucagon-like peptide 1 (GLP-1) analog administered subcutaneously once-weekly for the treatment of type 2 diabetes. These data ...
Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
- Phase II clinical trial investigating the effectiveness of Intercell's Vaccine Enhancement (VE) Patch in combination with an injectable H5N1 pandemic influenza vaccine started today in the U.S.
- The study is fully funded by HHS - this is the second study conducted under a 5 year USD 128 m ...
Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
-Clinical study planned for relapsed / refractory acute myelogenous leukemia-
PRINCETON, N.J., May 27 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today the allowance of an investigational
new drug application (IND) filed with the U.S. Food & Drug Administration (FD...
Investigational in Medical Products
PROCLEIX® West Nile Virus (WNV) Assay
Description:...Lung, and Blood Institute, which has been used to develop the Procleix WNV Assay. This assay was made available for use by U.S. blood centers under an investigational
New Drug Application (IND) on July 1, 2003, and currently screens over 80% of the blood supply....
IBS Interbody Spacer
use spacer with Cantilever Transforminal Lumbar Interbody Fusion and instrumentation. For investigational
use only. 7 mm height....
Company:Ortho Development Corporation
A to Z Drug Facts, 6th Edition
Features:... Rx, OTC, orphan, and investigational
drugs A searchable index of Canadian drugs by Trade name Indications for labeled, unlabeled and orphan uses Side effects organized by body system ...
Investigational in Medical Dictionary
...ns and Irritations. Diseases and Disorders ... Tired of reading glasses or bifocals? Learn about surgery to correct your presbyopia , including investigational
procedures. ... about what causes presbyopia . ... Presbyopia is a condition in which the lens of the eye loses its ability to ... Presbyo...
...and treatment. Organizes and supports research on macular degeneration and its treatments. Provides information on symptoms, risk factors, investigational
and approved therapies, news, and FAQs on age-related macular degeneration (ARMD) This large-type web site is dedicated to help the patients w...
...rs symptoms, causes, treatment of this ... Farsightedness ( hyperopia ) is a common vision condition ... Surgical Reversal of Presbyopia is an investigational
procedure not yet ... As a person with hyperopia you have several options available to you to enhance ... Hyperopia describes appropriate exam...
... Cardiac catheterization (heart cath) is the insertion of a catheter into a chamber or vessel of the heart. This is done for both investigational
and interventional purposes. Coronary catheterization is a subset of this... Cardiac catheterization is a test used to check blood flow in...
Investigational in Biological News
Green tea may affect prostate cancer progression
...consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate cancer progression.
agent used in the trial, Polyphenon E (provided by Polyphenon Pharma) may have the potential to lower the incidence and slow the progression of prosta...
Brain-computer interface, developed at Brown, begins new clinical trial
... PROVIDENCE, R.I. [Brown University] BrainGate, an investigational
technology being developed to detect brain signals and to allow people with...his multidisciplinary, multi-institutional effort. A new academically based investigational
Device Exemption (IDE) application BrainGate2 was developed in 2008 to fo...
REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
...e by promoting the body's intrinsic tolerogenic pathways using RGI-2001.
RGI-2001 is in late preclinical development and REGiMMUNE plans to file an investigational
New Drug (IND) for the prevention of acute GvHD associated with bone marrow transplantation later this year.
The poster presentation is scheduled d...
NIH announces new program to develop therapeutics for rare and neglected diseases
...ocess itself, developing new approaches to accelerate it and make it less expensive.
If a compound does survive this preclinical stage and receives investigational
New Drug status from the U.S. Food and Drug Administration, TRND will work to find a company willing to test the therapy in patients. Clinical trials...
Society of Interventional Radiology Foundation awards $191,000 in grants
...l Markers of Recurrence of Fibroids," Washington, D.C.;
Waleed Brinjikji, Mayo Clinic, Rochester, Minn., "Analysis of Crossover and Blinding in the investigational
Vertebroplasty Efficacy and Safety Trial (INVEST)";
Valentin Lance, "Radiologic and Microarray (Radiogenomic) Analysis of Gastric Adenocarcinoma: A...
UTSA, Health Science Center collaborate with Merck & Co. to develop chlamydia vaccine
...wide basic research, Merck Research Laboratories. "We look forward to working closely to translate the promising early results of the UT team into an investigational
candidate that together we can then advance toward the clinic."
"This is an exciting development in the fight against infectious diseases, highligh...
Biolex presents Locteron US Phase 2a hepatitis C data at EASL
... combination of improved tolerability and convenience."
Locteron is an investigational
therapeutic candidate and has not been approved for sale by the United Stat...mechanism, the currently approved products, Pegasys and PEG-Intron, and the investigational
product Albuferon, are immediate-release products that lack a controlled-re...
Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck
...nnounced that they have signed an exclusive worldwide license agreement for CDA-1 and CDB-1 (also known as MDX-066/MDX-1388 and MBL-CDA1/MBL-CDB1), an investigational
fully human monoclonal antibody combination developed to target and neutralize Clostridium difficile toxins A and B, for the treatment of C. diffic...
New test for breast cancer will help guide treatment choices
...longer have to endure needless chemotherapy.
Women whose tumors indicate a resistance to current treatments will be referred to clinical trials of investigational
drugs and treatments, opening the door to more effective medications in the future.
The group is currently designing prospective clinical trials u...
Franklin Square to study airway bypass procedure for severe emphysema
...tober 27, 2008 (Baltimore, MD)Franklin Square Hospital Center announces the start of the EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational
treatment for advanced widespread emphysema/COPD. The trial focuses on airway bypass, a bronchoscopic procedure designed to reduce lung hyperinflation...
Investigational in Biological Technology
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
COLLEGEVILLE, Pa., June 11 /PRNewswire-FirstCall/ -- New data from Phase 3 European clinical trials reinforce that Wyeth's (NYSE: WYE ) investigational
pneumococcal vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine, 13-valent [Adsorbed]), has the potential to provide cov...
FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418
BONITA SPRINGS, Fla., March 4 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, today announced that its Investigational
New Drug (IND) application for the Company's geranylgeranyltransferase inhibitor (GGTI-2418) has been accepted by the U.S. Food and Drug A...
Medarex Announces Allowance of Investigational New Drug Application for Company's First Antibody-Drug Conjugate, MDX-1203
PRINCETON, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today the allowance of an investigational
new drug (IND) application filed with the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company's first Antibody-Drug Conjugate (ADC) candidate gener...
International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System
SAN DIEGO, Jan. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies, Inc., today announced that Thomas E. Ahlering, M.D., Professor and Vice Chair of the Department of Urology at the University of California, Irvine , and a pioneer...
Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia
Results of Two Trials Identify Potential Initiation Dosing Regimen
TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Paliperidone palmitate, an investigational
long-acting therapy (LAT) demonstrated statistically significant symptom control compared with placebo according to the results of a 13-w...
Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
Separate Retrospective Analysis of Phase 3 Data Offers Additional
Information on Bazedoxifene Alone
COLLEGEVILLE, Pa., Sept. 25 /PRNewswire/ -- A retrospective analysis of
Phase 3 two-year data presented at the annual meeting of the North American
Menopause Society (NAMS) suggest that postme...
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
EAST SETAUKET, N.Y., Aug. 19 /PRNewswire-FirstCall/ -- Lixte
Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today
that the National Institute of Neurological Disorders and Stroke (NINDS),
National Institutes of Health (NIH) and Lixte filed a joint patent
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals
(Nasdaq: SGXP ) today announced that it has submitted an investigational
drug (IND) application to the U.S. Food and Drug Administration for SGX393.
This compound is an internally developed, selective, orally-bioavailable
U.S. Food and Drug Administration Advisory Committee Recommends Approval of Tolvaptan, an Investigational Treatment for Hyponatremia
PRINCETON, N.J., Jun. 25 /PRNewswire/ -- The U.S. Food and Drug
Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs
voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical
Development & Commercialization, Inc.'s (OPDC) investigational
for patients wi...
Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma
Results of phase I/II study highlighted in oral presentation at conference on malignant lymphoma
LUGANO, Switzerland, June 5 /PRNewswire-FirstCall/ -- At the 10th
International Conference on Malignant Lymphoma in Lugano, Switzerland data
were presented from a phase I/II ...